therivabio.com - שווי כולל של החברה TOVX
Theriva Biologics, Inc. (TOVX) minimizes risks by developing microbiome protection agents and antiviral oncology drugs. The company implements AI models and bioreactor automation to eliminate human error during production. High standing within the scientific community confirms the reliability of its clinical profile. The share price visualized below on GURU.Markets is 0.03, reflecting the current market valuation of the business.
Theriva Biologics, Inc. (TOVX) - פילוחי מדדים ודוחות פיננסיים
Enterprise value combines market capitalization with net debt, determining the actual price for a full buyout of the business minus liquid assets. When analyzing the enterprise value of Theriva Biologics, Inc. (TOVX), an investor must weigh it against the high risks of oncolytic virus clinical trials, as any development failure could instantaneously wipe out the capital investments embedded in this metric.